The payer's dilemma: recognizing the uncertainty of clinical and economic evidence at product launch.
Watkins
John B
JB
Sullivan
Sean D
SD
D003362:Cost-Benefit Analysis; D003657:Decision Making; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000191:economics; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use; D019458:Insurance Coverage / Q000191:economics* / Q000458:organization & administration; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D008329:Managed Care Programs / Q000191:economics*; D004364:Pharmaceutical Preparations / Q000191:economics
D007004:Hypoglycemic Agents; D004364:Pharmaceutical Preparations